(Q57258716)

Gynecomastia in Adolescent Boys

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

Epidemic of breast enlargement in an Italian school

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

Hormonal studies and physical maturation in adolescent gynecomastia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

Gynecomastia as a Physical Finding in Normal Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

Declining testicular function with age. Hormonal and clinical correlates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

Reproductive hormones in aging men. I. Measurement of sex steroids, basal luteinizing hormone, and Leydig cell response to human chorionic gonadotropin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

Twenty-four hour profiles of circulating androgens and oestrogens in male puberty with and without gynaecomastia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

Role of testosterone and dihydrotestosterone in spontaneous gynecomastia of adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

Complications of androgen deprivation therapy in men with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

Side effects of androgen deprivation therapy: monitoring and minimizing toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

Managing complications of androgen deprivation therapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

Andropause: Symptom Management for Prostate Cancer Patients Treated With Hormonal Ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

Gynecomastia in patients with prostate cancer: a review of treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

Bicalutamide as Immediate Therapy Either Alone or as Adjuvant to Standard Care of Patients with Localized or Locally Advanced Prostate Cancer: First Analysis of the Early Prostate Cancer Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

Efavirenz-associated breast hypertrophy in HIV-infection patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

Gynecomastia without lipodystrophy syndrome in HIV-infected men treated with efavirenz

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

Gynaecomastia without lipodystrophy in HIV-1-seropositive patients on efavirenz: an alternative hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

Efavirenz-associated gynecomastia: report of five cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

Breast enlargement in 13 men who were seropositive for human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

Cimetidine, a Histamine H2Receptor Antagonist, Occupies Androgen Receptors*

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

Risk of gynaecomastia associated with cimetidine, omeprazole, and other antiulcer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

Gynaecomastia associated with cimetidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

Cimetidine-induced impotence and breast changes in patients with gastric hypersecretory states

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

Painful gynaecomastia during omeprazole therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

Endocrine adverse effects of omeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

Gynaecomastia associated with proton pump inhibitors: a case series from the Spanish Pharmacovigilance System.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

Studies on the Interactions between Drug and Estrogen. II. On the Inhibitory Effect of 29 Drugs Reported to Induce Gynecomastia on the Oxidation of Estradiol at C-2 or C-17

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

Effects of five days verapamil administration on serum GH and PRL levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

Hyperprolactinaemia and impotence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

21 January 2018

Amlodipine gynaecomastia

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

Pathophysiology of spironolactone-induced gynecomastia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

Gynecomastia induced in normal males by spironolactone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

Gynecomastia and semen abnormalities induced by spironolactone in normal men

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

Disorders of the endocrine system due to radiation and cytotoxic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

Male breast cancer during finasteride therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

The influence of finasteride on the development of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

Efficacy and safety of dutasteride in the four-year treatment of men with benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

The promise of atypical antipsychotics: fewer side effects mean enhanced compliance and improved functioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

Possible individual and gender differences in the small increases in plasma prolactin levels seen during clozapine treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

Clinical implications of antipsychotic-induced hyperprolactinemia in patients with schizophrenia spectrum or bipolar spectrum disorders: recent developments and current perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

A randomized double-blind 12-week study of quetiapine, risperidone or fluphenazine on sexual functioning in people with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

The second-generation 'atypical' antipsychotics: similar improved efficacy but different neuroendocrine side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

Medication-induced hyperprolactinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

Pharmacology and toxicity of high-dose ketoconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

Classification and management of gynecomastia: defining the role of ultrasound-assisted liposuction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

Treatment of gynecomastia with tamoxifen: a double-blind crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

Management of physiological gynaecomastia with tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

Beneficial effects of raloxifene and tamoxifen in the treatment of pubertal gynecomastia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

The role of tamoxifen in the management of gynaecomastia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

Safety and efficacy of anastrozole for the treatment of pubertal gynecomastia: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

Evaluation of tamoxifen and anastrozole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

Prevention and management of bicalutamide-induced gynecomastia and breast pain: randomized endocrinologic and clinical studies with tamoxifen and anastrozole

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

Efficacy of tamoxifen and radiotherapy for prevention and treatment of gynaecomastia and breast pain caused by bicalutamide in prostate cancer: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382

Incidence of gynaecomastia in 954 young males and its relationship to somatometric parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802442382